Malignant Sinonasal Neoplasm — Trials

Malignant Sinonasal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

70 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 31
Recruiting: 18
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07645846	Neoadjuvant Docetaxel, Cisplatin, and Dual Immunotherapy for Sinonasal Carcinoma(PANDA)	not yet recruiting	Phase 2	23	Sun Yat-sen UniversityOTHER	0	Jun 25, 2026	clinicaltrials
NCT07563088	SPARE-1st: Surgery Alone vs Surgery Plus Postoperative Radiotherapy for Sinonasal Adenoid Cystic Carcinoma(SPARE-1st)	not yet recruiting	—	200	Eye & ENT Hospital of Fudan UniversityOTHER